Ispire Technology (ISPR) vs Mannatech (MTEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ispire Technology (ISPR) has outperformed Mannatech (MTEX) over the past year, losing 43.6% versus a loss of 73.8%. Ispire Technology is the larger company by market cap ($71.1 million vs $4.9 million), about 14.4 times the size, while Mannatech is growing revenue faster (-8.3% vs -24.7%). Mannatech converts more of its revenue into profit, with a net margin of -14.1% versus -34.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ISPR | MTEX |
|---|---|---|
| Share price | $1.23 | $2.56 |
| Market cap | $71.05M | $4.94M |
| 1-day change | -3.15% | +5.13% |
| YTD return | -56.07% | -68.97% |
| 1-year return | -43.58% | -73.80% |
| 5-year return | — | -93.33% |
| EPS (TTM) | $-0.64 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $96.01M | $108.04M |
| Revenue growth (YoY) | -24.69% | -8.34% |
| Net income (latest FY) | $-33.20M | $-15.21M |
| Gross margin | 12.81% | 74.94% |
| Operating margin | -33.95% | -0.39% |
| Net margin | -34.58% | -14.08% |
| 52-week high | $3.87 | $9.97 |
| 52-week low | $1.01 | $2.32 |
| Distance from 52-week high | -68.22% | -74.32% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +298.37% | — |
| Average volume | 20.51K | 37.23K |
| Shares outstanding | 57.77M | 1.93M |
| Employees | 88 | 170 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ispire Technology is about 14.4 times larger than Mannatech by market value ($71.05M vs $4.94M).
- ISPR has outperformed MTEX by 30.2 percentage points over the past year.
- Mannatech is more profitable, keeping -14.1 cents of every revenue dollar as net income versus -34.6 cents for Ispire Technology.
- Mannatech grew revenue faster in its latest fiscal year (-8.34% vs -24.69%).
About Ispire Technology
ISPR stock →Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Aspire brands.
Health Care · Medicinal Chemicals and Botanical Products · 88 employees
About Mannatech
MTEX stock →Mannatech, Incorporated operates as a wellness solution provider. The company develops markets and sells nutritional supplements; skin care and anti-aging products; and weight-management and fitness products.
Health Care · Medicinal Chemicals and Botanical Products · 170 employees
ISPR vs MTEX FAQ
Which is bigger, Ispire Technology or Mannatech?
Ispire Technology (ISPR) is larger, with a market capitalization of $71.05M compared with $4.94M for Mannatech (MTEX).
Which stock has performed better over the past year, ISPR or MTEX?
ISPR returned -43.58% over the past 12 months, compared with -73.80% for MTEX (price return, excluding dividends). Past performance does not predict future results.
Are Ispire Technology and Mannatech in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.